LAZAR DAVID E. purchased 201.4% of their position (2.23M shares) of TITAN PHARMACEUTICALS INC on the open market
Open‑market purchase worth $1.92M — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 7/8/2022ACC: 0001829126-22-014209
+2.23M
Net shares
Net buyer
$1.92M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
2.23M acquired
Non-Derivative Transactions3
Common Stock, par value $0.001
Direct
Shares
+1.17M
Price / share
$0.77
Trade value
$901.88K
% of position
82.0%
7/6/2022
1.42M→2.59M
Common Stock, par value $0.001
Indirect
Shares
+315.92K
Price / share
$0.89
Trade value
$281.99K
% of position
732.2%
7/6/2022
43.15K→359.07K
Common Stock, par value $0.001
Direct
Shares
+744.29K
Price / share
$0.99
Trade value
$739.01K
% of position
28.8%
7/7/2022
2.59M→3.33M
Total
Net shares
+2.23M
Net value
$1.92M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 Direct | 7/6/2022 | P · Purchase | +1.17M | $0.77 | $901.88K | 82.0% | 1.42M | 2.59M |
| Common Stock, par value $0.001 Indirect | 7/6/2022 | P · Purchase | +315.92K | $0.89 | $281.99K | 732.2% | 43.15K | 359.07K |
| Common Stock, par value $0.001 Direct | 7/7/2022 | P · Purchase | +744.29K | $0.99 | $739.01K | 28.8% | 2.59M | 3.33M |
| Total | +2.23M | $1.92M | ||||||
Derivative Transactions0
No derivative transactions reported